“…The overexpression of sialic acid-rich regions in cancer calls [ 118 ] can contribute to the creation of a negative charge on cell surfaces which, in turn, increases their interaction with positive charged AuNPs [ 119 ]. Many other types of molecules, (i.e., rifampicin, cytosine-phosphate-guanine oligonucleotides, and amphiphilic drugs such the small molecule Toll-like receptor agonist resiquimod (R848)) have recently been used to functionalize AuNPs in order to increase their target specificity, cellular uptake rate, immune stimulation and therapeutic properties [ 120 , 121 , 122 ]. Despite a vast number of scientific papers confirming the important role of the surface functionalization with specific ligands as strategy to improve biocompatibility both in vitro and in vivo, and so to allow for the development of high precision therapy and/or diagnosis, a recent review by Goddard et al has highlighted that each targeting ligand has both benefits and drawback and argued that it is necessary to make comparisons between different targeting modalities for the same receptor to establish the most effective targeting approach [ 38 ].…”